CDTX icon

Cidara Therapeutics
CDTX

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$181
18% downside
High target

5 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Guggenheim
Guggenheim
Seamus Fernandez
100% 1-yr CDTX win rate
18 Nov ‘25 26 days ago
HC Wainwright & Co
HC Wainwright & Co
Sara Nik
100% 1-yr CDTX win rate
14 Nov ‘25 29 days ago
Needham
Needham
Joseph Stringer
63% 1-yr CDTX win rate
14 Nov ‘25 29 days ago
RBC Capital
RBC Capital
Brian Abrahams
100% 1-yr CDTX win rate
7 Nov ‘25 1 month ago
Morgan Stanley
Morgan Stanley
Maxwell Skor
100% 1-yr CDTX win rate
16 Oct ‘25 1 month ago
JP Morgan
JP Morgan
Anupam Rama
100% 1-yr CDTX win rate
10 Oct ‘25 2 months ago
WBB Securities
WBB Securities
Steve Brozak
100% 1-yr CDTX win rate
9 Oct ‘25 2 months ago
Citizens
Citizens
Roy Buchanan
75% 1-yr CDTX win rate
3 Oct ‘25 2 months ago